Rebirth

Rebirth Bio is a biotechnology company focused on the field of longevity and regenerative medicine through cellular reprogramming. The company utilizes a proprietary platform to deliver specific transcription factors, often referred to as Yamanaka factors, to reset the epigenetic state of aged or damaged cells to a more youthful and functional condition. By targeting the fundamental biological drivers of aging, Rebirth Bio aims to develop therapies that can reverse cellular decline and treat a wide range of age-related chronic diseases. Their approach seeks to restore tissue function and extend human healthspan by leveraging the body's innate regenerative potential.